Study to Validate the Use of a Lymphatic Imaging Protocol to Stage Disease Severity in Patients with Lymphedema


About this study

The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and serve as a biomarker for microsurgical treatment response.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult (18+ years of age).
  • Ability to provide oral consent.
  • Has been diagnosed with Lymphedema.

Exclusion Criteria: 

  • Under the age of 18 years old.
  • Inability to provide oral consent.
  • previous lymphovenous bypass or lymph node transfer surgery.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Antonio Forte, M.D., Ph.D.

Contact us for the latest status

Contact information:

Mauricia Buchanan R.N.

More information


Publications are currently not available